Bluespine Raises $7.2 Million in Seed Funding to Help Self-Insured Employers Tackle Medical Overbilling
Summary
AI-powered platform enables large employers to discover, recover, and prevent healthcare overspending; Alliant Insurance Services, Mattel among companies using BluespineNEW YORK, Nov. 13, 2024 /PRNewswire/ -- Bluespine, an AI-driven claims cost reduction platform for self-insured employers, today announced it has raised $7.2 million in a seed funding round led by Team8, with participation from strategic partners, to tackle medical overbilling, which is a symptom of the $300 billion fraud, waste, and abuse (FWA) healthcare crisis. The company was established under Team8s unique Venture Creation model, led by Team8 Partner Galia Beer-Gabel.Together, Bluespines founders have assembled an early team of subject matter experts with a combined 25 years of experience working with leading US carriers. "Solving the financial dimension of healthcare wont fix everything, but it can drive efficiencies that ultimately enhance patient care," said Team8 Managing Partner Rakefet Russak-Aminoach. Founded in 2023 by a team of seasoned technology and cybersecurity experts, Bluespines mission is to reduce wasteful healthcare spending and empower companies to better serve their employees health needs. For more information about Bluespine and its AI-powered healthcare cost-reduction solution, visit https://www.bluespine.io/.About Team8Team8 is a global Venture-Creation and Venture Capital Fund that creates and invests in companies focusing on Cybersecurity, Data & AI, Fintech, and Digital Health.